167 related articles for article (PubMed ID: 17971072)
1. MMP-2, -3 and -9 levels and activity are not related to Abeta load in the frontal cortex in Alzheimer's disease.
Baig S; Kehoe PG; Love S
Neuropathol Appl Neurobiol; 2008 Apr; 34(2):205-15. PubMed ID: 17971072
[TBL] [Abstract][Full Text] [Related]
2. Genetic association between matrix metalloproteinase MMP-9 and MMP-3 polymorphisms and Japanese sporadic Alzheimer's disease.
Shibata N; Ohnuma T; Higashi S; Usui C; Ohkubo T; Kitajima A; Ueki A; Nagao M; Arai H
Neurobiol Aging; 2005 Jul; 26(7):1011-4. PubMed ID: 15748780
[TBL] [Abstract][Full Text] [Related]
3. Impact of the matrix metalloproteinase MMP-3 on dementia.
Helbecque N; Cottel D; Hermant X; Amouyel P
Neurobiol Aging; 2007 Aug; 28(8):1215-20. PubMed ID: 16822591
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase 3 haplotypes and plasma amyloid beta levels: the Rotterdam Study.
Reitz C; van Rooij FJ; Soares HD; de Maat MP; Hofman A; Witteman JC; Breteler MM
Neurobiol Aging; 2010 Apr; 31(4):715-8. PubMed ID: 18606478
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy.
Miners JS; Ashby E; Van Helmond Z; Chalmers KA; Palmer LE; Love S; Kehoe PG
Neuropathol Appl Neurobiol; 2008 Apr; 34(2):181-93. PubMed ID: 17973905
[TBL] [Abstract][Full Text] [Related]
6. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
[TBL] [Abstract][Full Text] [Related]
7. Neuronal TIMP-1 release accompanies astrocytic MMP-9 secretion and enhances astrocyte proliferation induced by beta-amyloid 25-35 fragment.
Hernández-Guillamon M; Delgado P; Ortega L; Pares M; Rosell A; García-Bonilla L; Fernández-Cadenas I; Borrell-Pagès M; Boada M; Montaner J
J Neurosci Res; 2009 Jul; 87(9):2115-25. PubMed ID: 19235898
[TBL] [Abstract][Full Text] [Related]
8. Ibuprofen and lipoic acid codrug 1 control Alzheimer's disease progression by down-regulating protein kinase C ε-mediated metalloproteinase 2 and 9 levels in β-amyloid infused Alzheimer's disease rat model.
Zara S; Rapino M; Sozio P; Di Stefano A; Nasuti C; Cataldi A
Brain Res; 2011 Sep; 1412():79-87. PubMed ID: 21820649
[TBL] [Abstract][Full Text] [Related]
9. Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease.
Okamoto K; Mimura K; Murawaki Y; Yuasa I
J Gastroenterol Hepatol; 2005 Jul; 20(7):1102-8. PubMed ID: 15955221
[TBL] [Abstract][Full Text] [Related]
10. Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress.
Lee KW; Kim JB; Seo JS; Kim TK; Im JY; Baek IS; Kim KS; Lee JK; Han PL
J Neurochem; 2009 Jan; 108(1):165-75. PubMed ID: 19012747
[TBL] [Abstract][Full Text] [Related]
11. The promoter polymorphism of the matrix metalloproteinase 3 (MMP-3) gene in women with ovarian cancer.
Szyllo K; Smolarz B; Romanowicz-Makowska H; Niewiadomski M; Kozlowska E; Kulig A
J Exp Clin Cancer Res; 2002 Sep; 21(3):357-61. PubMed ID: 12385578
[TBL] [Abstract][Full Text] [Related]
12. [Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma].
Lu ZQ; Wang YM; Cao YY; Zhang QJ; Zhang XH; Li YH; Wang HS; Xie HL; Jiao BH; Zhang JH
Ai Zheng; 2007 May; 26(5):463-8. PubMed ID: 17672933
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms.
Nanni S; Melandri G; Hanemaaijer R; Cervi V; Tomasi L; Altimari A; Van Lent N; Tricoci P; Bacchi L; Branzi A
Transl Res; 2007 Mar; 149(3):137-44. PubMed ID: 17320799
[TBL] [Abstract][Full Text] [Related]
14. PCR analysis of matrix metalloproteinase 3 (MMP-3) gene promoter polymorphism in ovarian cancer.
Smolarz B; Szyłło K; Romanowicz-Makowska H; Niewiadomski M; Kozłowska E; Kulig A
Pol J Pathol; 2003; 54(4):233-8. PubMed ID: 14998290
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain.
Asahina M; Yoshiyama Y; Hattori T
Clin Neuropathol; 2001; 20(2):60-3. PubMed ID: 11327298
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms at the paraoxonase 1 L55M and Q192R loci affect the pathophysiology of Alzheimer's disease: emphasis on the cholinergic system and beta-amyloid levels.
Leduc V; Poirier J
Neurodegener Dis; 2008; 5(3-4):225-7. PubMed ID: 18322397
[TBL] [Abstract][Full Text] [Related]
17. Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms.
Lee J; Fukumoto H; Orne J; Klucken J; Raju S; Vanderburg CR; Irizarry MC; Hyman BT; Ingelsson M
Exp Neurol; 2005 Jul; 194(1):91-6. PubMed ID: 15899246
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloprotease-9 inhibition improves amyloid beta-mediated cognitive impairment and neurotoxicity in mice.
Mizoguchi H; Takuma K; Fukuzaki E; Ibi D; Someya E; Akazawa KH; Alkam T; Tsunekawa H; Mouri A; Noda Y; Nabeshima T; Yamada K
J Pharmacol Exp Ther; 2009 Oct; 331(1):14-22. PubMed ID: 19587312
[TBL] [Abstract][Full Text] [Related]
19. Association between IL-6 and MMP-3 gene polymorphisms and adolescent idiopathic scoliosis: a case-control study.
Aulisa L; Papaleo P; Pola E; Angelini F; Aulisa AG; Tamburrelli FC; Pola P; Logroscino CA
Spine (Phila Pa 1976); 2007 Nov; 32(24):2700-2. PubMed ID: 18007247
[TBL] [Abstract][Full Text] [Related]
20. TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease.
Culpan D; Cram D; Chalmers K; Cornish A; Palmer L; Palmer J; Hughes A; Passmore P; Craig D; Wilcock GK; Kehoe PG; Love S
Neurobiol Aging; 2009 Jul; 30(7):1052-60. PubMed ID: 18069092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]